Reduction in the Intensity of Abortive Migraine Drug Use During Coumarin Therapy

Autor: H. Rahimtoola, Henk Buurma, C.C. Tijssen, Hubert G. M. Leufkens, Antoine C. G. Egberts

Publikováno v: Headache: The Journal of Head and Face Pain. 41:768-773

Objective.—To investigate the impact of coumarin therapy on migraine attack frequency. Background.—Sporadic case reports and clinical studies have described beneficial effects of coumarin therapy on migraine severity. Design and Methods.—A retr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b534f869b153421e2ebfb3a4e5a6ef
https://doi.org/10.1046/j.1526-4610.2001.01141.x

Familial Brain Tumours : A Commented Register

Autor: C.C. Tijssen, M.R. Halprin, L.J. Endtz

Heredity, environment, the role of infectious agents, and other influences have been cited within a multiplicity of factors of possible relevance to the problem of neoplasm etiology. In some cases, such as that of retinoblastoma the influence of here

Incidence and determinants of antidepressant drug use in migraine patients

Autor: Antoine C. G. Egberts, H. Rahimtoola, C.C. Tijssen, Henk Buurma, Hubert G. M. Leufkens

Publikováno v: International clinical psychopharmacology. 18(6)

The purpose of this retrospective, follow-up study was to characterise the use of antidepressant medication in a defined migraine population and evaluate the determinants thereof. Data was obtained from the PHARMO-RLS prescription database. Our migra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a42c1859a788b9c7c59e6799b3dce69
https://pubmed.ncbi.nlm.nih.gov/14571153

Migraine prophylactic medication usage patterns in The Netherlands

Autor: H. Rahimtoola, Antoine C. G. Egberts, Henk Buurma, C.C. Tijssen, Hubert G. M. Leufkens

This study aims to investigate usage patterns of specific migraine prophylactic medications in ergotamine and triptan patients commencing this treatment for the first time during 1 January 1992 until 31 December 1998. Usage patterns of specific migra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::548eab45e0c9c28151992196f13b371d
https://dspace.library.uu.nl/handle/1874/27514

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2

Autor: N.C. Oskam, A. M. W. Van Den Ouweland, C.C. Tijssen, M.A.J.A. Hermsen, Andries Westerveld, Theo J. M. Hulsebos, Engelien H. Bijleveld, Ben C.J. Hamel

Publikováno v: British journal of cancer, 81(7), 1150-1154. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 81, 1150-1154. Nature Publishing Group
Hulsebos, T J M, Oskam, N C, Bijleveld, E H, Westerveld, A, Hermsen, M A J A, van den Ouweland, A M W, Hamel, B C & Tijssen, C C 1999, ' Evidence for a ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. ', British Journal of Cancer, vol. 81, pp. 1150-1154 . https://doi.org/10.1038/sj.bjc.6690822
British Journal of Cancer, 81(7), 1150-1154. Nature Publishing Group

Ependymomas are glial tumours of the brain and spinal cord. The most frequent genetic change in sporadic ependymoma is monosomy 22, suggesting the presence of an ependymoma tumour suppressor gene on that chromosome. Clustering of ependymomas has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd6a62a2a04822d235301faeb2236a56
https://pure.amc.nl/en/publications/evidence-for-an-ependymoma-tumour-suppressor-gene-in-chromosome-region-22pter22q112(22395a74-ec17-4da7-ba6c-d4f40a1b3ad7).html